All Stories

  1. Increased fibrinolysis-induced bradykinin formation in hereditary angioedema confirmed using stored plasma and biotechnological inhibitors

    Article • BMC Research Notes, May 2019, Springer Science + Business Media

    Professor François Marceau

  2. Comparing Pathways of Bradykinin Formation in Whole Blood From Healthy Volunteers and Patients With Hereditary Angioedema Due to C1 Inhibitor Deficiency

    Article • Frontiers in Immunology, October 2018, Frontiers

    Professor François Marceau

  3. Bifunctional ligands of the bradykinin B 2 and B 1 receptors: An exercise in peptide hormone plasticity

    Article • Peptides, July 2018, Elsevier

    Professor François Marceau

  4. Bifunctional fusion proteins containing the sequence of the bradykinin homologue maximakinin: activities at the rat bradykinin B2 receptor

    Article • Canadian Journal of Physiology and Pharmacology, May 2018, Canadian Science Publishing

    Professor François Marceau

  5. D-Arg0-Bradykinin-Arg-Arg, a Latent Vasoactive Bradykinin B2 Receptor Agonist Metabolically Activated by Carboxypeptidases

    Article • Frontiers in Pharmacology, March 2018, Frontiers

    Professor François Marceau

  6. Editorial: Correspondence from Chirumbolo and Bjorklund

    Article • International Immunopharmacology, February 2018, Elsevier

    Professor François Marceau

  7. Production and evaluation of parathyroid hormone receptor1 ligands with intrinsic or assembled peroxidase domains

    Article • Scientific Reports, October 2017, Nature

    Professor François Marceau

  8. S100A9 potentiates the activation of neutrophils by the etiological agent of gout, monosodium urate crystals

    Article • Journal of Leukocyte Biology, May 2017, Wiley

    Professor François Marceau

  9. Species-specific pharmacology of maximakinin, an amphibian homologue of bradykinin: putative prodrug activity at the human B2receptor and peptidase resistance in rats

    Article • PeerJ, January 2017, PeerJ

    Professor François Marceau

  10. Species-specific pharmacology of maximakinin, an amphibian homologue of bradykinin: putative prodrug activity at the human B2 receptor and peptidase resistance in rat

    Article • December 2016, PeerJ

    Professor François Marceau

  11. Species-specific pharmacology of maximakinin, an amphibian homologue of bradykinin: putative prodrug activity at the human B2 receptor and peptidase resistance in rat

    Article • December 2016, PeerJ

    Professor François Marceau

  12. Infrared-emitting, peptidase-resistant fluorescent ligands of the bradykinin B2 receptor: application to cytofluorometry and imaging

    Article • BMC Research Notes, September 2016, Springer Science + Business Media

    Professor François Marceau

  13. Editorial: Improving the data reproducibility and general interest of natural product submissions

    Article • International Immunopharmacology, August 2016, Elsevier

    Professor François Marceau

  14. Lysosomotropic cationic drugs induce cytostatic and cytotoxic effects: Role of liposolubility and autophagic flux and antagonism by cholesterol ablation

    Article • Toxicology and Applied Pharmacology, August 2016, Elsevier

    Professor François Marceau

  15. Introduction: Natural product-based drug discovery in Immunopharmacology

    Article • International Immunopharmacology, August 2016, Elsevier

    Professor François Marceau

  16. The isolated human umbilical vein as a bioassay for kinin-generating proteases: An in vitro model for therapeutic angioedema agents

    Article • Life Sciences, June 2016, Elsevier

    Professor François Marceau

  17. Biotechnological Fluorescent Ligands of the Bradykinin B1 Receptor: Protein Ligands for a Peptide Receptor

    Article • PLoS ONE, February 2016, PLOS

    Professor François Marceau

  18. In Vivo Effects of Bradykinin B2 Receptor Agonists with Varying Susceptibility to Peptidases

    Article • Frontiers in Pharmacology, January 2016, Frontiers

    Professor François Marceau

  19. Autophagic flux inhibition and lysosomogenesis ensuing cellular capture and retention of the cationic drug quinacrine in murine models

    Article • PeerJ, October 2015, PeerJ

    Professor François Marceau

  20. Book review: Evidence-based validation of herbal medicine, Elsevier, Amsterdam, 2015, Edited by P. K. Mukherjee. 537 pp. ISBN: 978-0-12-800874-4

    Article • International Immunopharmacology, July 2015, Elsevier

    Professor François Marceau

  21. Pharmacological profile of a bifunctional ligand of the formyl peptide receptor1 fused to the myc epitope

    Article • International Immunopharmacology, March 2015, Elsevier

    Professor François Marceau

  22. Pharmacological effects of recombinant human tissue kallikrein on bradykinin B 2 receptors

    Article • Pharmacology Research & Perspectives, February 2015, Wiley

    Professor François Marceau

  23. A tagged parathyroid hormone derivative as a carrier of antibody cargoes transported by the G protein coupled PTH1 receptor

    Article • Peptides, October 2014, Elsevier

    Professor François Marceau

  24. Pharmacological evidence of bradykinin regeneration from extended sequences that behave as peptidase–activated B2 receptor agonists

    Article • Frontiers in Pharmacology, March 2014, Frontiers

    Professor François Marceau

  25. Assessment of Cation Trapping by Cellular Acidic Compartments

    Article • January 2014, Elsevier

    Professor François Marceau

  26. Vasopeptidase-activated latent ligands of the histamine receptor-1

    Article • International Immunopharmacology, November 2013, Elsevier

    Professor François Marceau

  27. Green fluorescent protein fused to peptide agonists of two dissimilar G protein‐coupled receptors: novel ligands of the bradykinin B 2 (rhodopsin family) receptor and parathyroid hormone PTH 1 ...

    Article • Pharmacology Research & Perspectives, October 2013, Wiley

    Professor François Marceau

  28. High affinity capture and concentration of quinacrine in polymorphonuclear neutrophils via vacuolar ATPase-mediated ion trapping: Comparison with other peripheral blood leukocytes and implications for the distribution of cationic drugs

    Article • Toxicology and Applied Pharmacology, July 2013, Elsevier

    Professor François Marceau

  29. Inhibitory effects of cytoskeleton disrupting drugs and GDP-locked Rab mutants on bradykinin B2 receptor cycling

    Article • Pharmacological Research, May 2013, Elsevier

    Professor François Marceau

  30. Bifunctional epitope-agonist ligands of the bradykinin B2 receptor

    Article • Biological Chemistry, March 2013, De Gruyter

    Professor François Marceau

  31. C-C chemokine receptor-7 mediated endocytosis of antibody cargoes into intact cells

    Article • Frontiers in Pharmacology, January 2013, Frontiers

    Professor François Marceau

  32. NLRP3 promotes autophagy of urate crystals phagocytized by human osteoblasts

    Article • Arthritis Research & Therapy, January 2013, Springer Science + Business Media

    Professor François Marceau

  33. An in vitro reconstitution system to address the mechanism of the vascular expression of the bradykinin B1 receptor in response to angiotensin converting enzyme inhibition

    Article • Vascular Pharmacology, August 2012, Elsevier

    Professor François Marceau

  34. N-terminal extended conjugates of the agonists and antagonists of both bradykinin receptor subtypes: Structure–activity relationship, cell imaging using ligands conjugated with fluorophores and prospect for functionally active cargoes

    Article • Peptides, April 2012, Elsevier

    Professor François Marceau

  35. Prolonged signalling and trafficking of the bradykinin B2 receptor stimulated with the amphibian peptide maximakinin: Insight into the endosomal inactivation of kinins

    Article • Pharmacological Research, February 2012, Elsevier

    Professor François Marceau

  36. Cation trapping by cellular acidic compartments: Beyond the concept of lysosomotropic drugs

    Article • Toxicology and Applied Pharmacology, February 2012, Elsevier

    Professor François Marceau

  37. Met-Lys-bradykinin-Ser-Ser, a peptide produced by the neutrophil from kininogen, is metabolically activated by angiotensin converting enzyme in vascular tissue

    Article • Pharmacological Research, November 2011, Elsevier

    Professor François Marceau

  38. Bradykinin B2 receptor-mediated transport into intact cells: Anti-receptor antibody-based cargoes

    Article • European Journal of Pharmacology, October 2011, Elsevier

    Professor François Marceau

  39. Dissociation of the vacuolar and macroautophagic cytopathology from the cytotoxicity induced by the lipophilic local anesthetic bupivacaine

    Article • Canadian Journal of Physiology and Pharmacology, July 2011, Canadian Science Publishing

    Professor François Marceau

  40. 5 Drugs in the kallikrein-kinin system

    Article • January 2011, De Gruyter

    Professor François Marceau

  41. Kinins

    Article • January 2011, De Gruyter

    Professor François Marceau

  42. Design of Fluorescent Bradykinin Analogs: Application to Imaging of B2 Receptor-Mediated Agonist Endocytosis and Trafficking and Angiotensin-Converting Enzyme

    Article • Journal of Pharmacology and Experimental Therapeutics, January 2011, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Professor François Marceau

  43. Effect of interferon-γ on inflammatory cytokine-induced bradykinin B1 receptor expression in human vascular cells

    Article • European Journal of Pharmacology, November 2010, Elsevier

    Professor François Marceau

  44. Vascular smooth muscle contractility assays for inflammatory and immunological mediators

    Article • International Immunopharmacology, November 2010, Elsevier

    Professor François Marceau

  45. A ligand-based approach to investigate the expression and function of angiotensin converting enzyme in intact human umbilical vein endothelial cells

    Article • Peptides, August 2010, Elsevier

    Professor François Marceau

  46. Bradykinin forming capacity of oversulfated chondroitin sulfate contaminated heparin in vitro

    Article • Biomaterials, August 2010, Elsevier

    Professor François Marceau

  47. Guest Editorial for the Special Issue Peptide Receptors: Focus on Neuropeptides and Kinins

    Article • Neuropeptides, April 2010, Elsevier

    Professor François Marceau

  48. Altered cardiac bradykinin metabolism in experimental diabetes caused by the variations of angiotensin-converting enzyme and other peptidases

    Article • Neuropeptides, April 2010, Elsevier

    Professor François Marceau

  49. Vacuolar ATPase-mediated sequestration of local anesthetics in swollen macroautophagosomes

    Article • Canadian Journal of Anesthesia/Journal canadien d anesthésie, January 2010, Springer Science + Business Media

    Professor François Marceau

  50. Effects of inactivation-resistant agonists on the signalling, desensitization and down-regulation of bradykinin B2 receptors

    Article • British Journal of Pharmacology, September 2009, Wiley

    Professor François Marceau

  51. Vacuolar ATPase-Mediated Cellular Concentration and Retention of Quinacrine: A Model for the Distribution of Lipophilic Cationic Drugs to Autophagic Vacuoles

    Article • Drug Metabolism and Disposition, September 2009, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Professor François Marceau

  52. Tumor cells expressing tissue factor influence the migration of smooth muscle cells in a catalytic activity-dependent way

    Article • Canadian Journal of Physiology and Pharmacology, September 2009, Canadian Science Publishing

    Professor François Marceau

  53. Intracellular sequestration of amiodarone: role of vacuolar ATPase and macroautophagic transition of the resulting vacuolar cytopathology

    Article • British Journal of Pharmacology, August 2009, Wiley

    Professor François Marceau

  54. NTPDase1 (CD39) controls nucleotide-dependent vasoconstriction in mouse

    Article • Cardiovascular Research, July 2009, European Society of Cardiology

    Professor François Marceau

  55. Angiotensin converting enzyme inhibitor induced angio-oedema: a review of the pathophysiology and risk factors

    Article • Clinical & Experimental Allergy, July 2009, Wiley

    Professor François Marceau

  56. Receptor tyrosine kinases as mediators of injury-induced bradykinin B1 receptor expression in rabbit aortic smooth muscle

    Article • European Journal of Pharmacology, March 2009, Elsevier

    Professor François Marceau

  57. Fluorescent Ligands of the Bradykinin B1 Receptors: Pharmacologic Characterization and Application to the Study of Agonist-Induced Receptor Translocation and Cell Surface Receptor Expression

    Article • Journal of Pharmacology and Experimental Therapeutics, January 2009, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Professor François Marceau

  58. A fluorescent version of the bradykinin B2 receptor antagonist B-9430: Pharmacological characterization and use in live cell imaging

    Article • Peptides, September 2008, Elsevier

    Professor François Marceau

  59. Therapeutic options in inflammatory bowel disease: experimental evidence of a beneficial effect of kinin B1 receptor blockade

    Article • British Journal of Pharmacology, July 2008, Wiley

    Professor François Marceau

  60. Receptor-independent, vacuolar ATPase-mediated cellular uptake of histamine receptor-1 ligands: Possible origin of pharmacological distortions and side effects

    Article • Toxicology and Applied Pharmacology, June 2008, Elsevier

    Professor François Marceau

  61. Intense pseudotransport of a cationic drug mediated by vacuolar ATPase: Procainamide-induced autophagic cell vacuolization

    Article • Toxicology and Applied Pharmacology, May 2008, Elsevier

    Professor François Marceau

  62. Lack of direct interaction between enalaprilat and the kinin B1 receptors

    Article • Peptides, April 2008, Elsevier

    Professor François Marceau

  63. Structural modification of the highly potent peptide bradykinin B1 receptor antagonist B9958

    Article • International Immunopharmacology, February 2008, Elsevier

    Professor François Marceau

  64. Cardiovascular expression of inflammatory signaling molecules, the kinin B1 receptor and COX2, in the rabbit: Effects of LPS, anti-inflammatory and anti-hypertensive drugs

    Article • Regulatory Peptides, February 2008, Elsevier

    Professor François Marceau

  65. Trapping of adrenergic decongestant drugs into cellular endomembrane compartments: Toxicological and pharmacological consequences

    Article • International Immunopharmacology, December 2007, Elsevier

    Professor François Marceau

  66. B-9972 (D-Arg-[Hyp3,Igl5,Oic7,Igl8]-bradykinin) Is an Inactivation-Resistant Agonist of the Bradykinin B2 Receptor Derived from the Peptide Antagonist B-9430 (D-Arg-[Hyp3,Igl5,D-Igl7,Oic8]-bradykinin): Pharmacologic Profile and Effective Induction of R...

    Article • Journal of Pharmacology and Experimental Therapeutics, August 2007, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Professor François Marceau

  67. Ô miroir, dis-moi comment les amines effacent les rides

    Article • médecine/sciences, June 2007, EDP Sciences

    Professor François Marceau

  68. Does zaltoprofen antagonize the bradykinin receptors?

    Article • Regulatory Peptides, May 2007, Elsevier

    Professor François Marceau

  69. Generation of kinins during preparation and storage of whole blood?derived platelet concentrates

    Article • Transfusion, March 2007, Wiley

    Professor François Marceau

  70. The antiwrinkle effect of topical concentrated 2-dimethylaminoethanol involves a vacuolar cytopathology

    Article • British Journal of Dermatology, March 2007, Wiley

    Professor François Marceau

  71. Antagonist, partial agonist and antiproliferative actions of B-9870 (CU201) as a function of the expression and density of the bradykinin B1 and B2 receptors

    Article • British Journal of Pharmacology, February 2007, Wiley

    Professor François Marceau

  72. Bradykinin Receptors

    Article • January 2007, Elsevier

    Professor François Marceau

  73. B-2 Bradykinin Receptor

    Article • January 2007, Elsevier

    Professor François Marceau

  74. B-1 Bradykinin Receptor

    Article • January 2007, Elsevier

    Professor François Marceau

  75. Role of Nuclear Factor-κB and Protein Kinase C Signaling in the Expression of the Kinin B1 Receptor in Human Vascular Smooth Muscle Cells

    Article • Molecular Pharmacology, December 2006, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Professor François Marceau

  76. The bradykinin B2 receptor antagonist icatibant (Hoe 140) blocks aminopeptidase N at micromolar concentrations: Off-target alterations of signaling mediated by the bradykinin B1 and angiotensin receptors

    Article • European Journal of Pharmacology, December 2006, Elsevier

    Professor François Marceau

  77. Inhibition of human and rabbit arterial smooth muscle cell migration mediated by the kinin B 1 receptor: role of receptor density and released mediators

    Article • Canadian Journal of Physiology and Pharmacology, November 2006, Canadian Science Publishing

    Professor François Marceau

  78. Advances in the Development of Bradykinin Receptor Ligands

    Article • Current Topics in Medicinal Chemistry, July 2006, Bentham Science Publishers

    Professor François Marceau

  79. Molecular identification and pharmacological profile of the bovine kinin B1 receptor

    Article • Biological Chemistry, February 2006, De Gruyter

    Professor François Marceau

  80. A Nonpeptide Antagonist Reveals a Highly Glycosylated State of the Rabbit Kinin B1 Receptor

    Article • Molecular Pharmacology, January 2006, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Professor François Marceau

  81. Dual antagonists of the bradykinin B1 and B2 receptors based on a postulated common pharmacophore from existing non-peptide antagonists

    Article • Biological Chemistry, January 2006, De Gruyter

    Professor François Marceau

  82. Discovery of a Dual-Function Peptide That Combines Aminopeptidase N Inhibition and Kinin B1Receptor Antagonism

    Article • Journal of Pharmacology and Experimental Therapeutics, December 2005, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Professor François Marceau

  83. N-Substituted 4-Aminobenzamides (Procainamide Analogs): An Assessment of Multiple Cellular Effects Concerning Ion Trapping

    Article • Molecular Pharmacology, September 2005, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Professor François Marceau

  84. Expression of Metallopeptidases and Kinin Receptors in Swine Oropharyngeal Tissues: Effects of Angiotensin I-Converting Enzyme Inhibition and Inflammation

    Article • Journal of Pharmacology and Experimental Therapeutics, September 2005, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Professor François Marceau

  85. Endogenous Aminopeptidase N Decreases the Potency of Peptide Agonists and Antagonists of the Kinin B1 Receptors in the Rabbit Aorta

    Article • Journal of Pharmacology and Experimental Therapeutics, May 2005, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Professor François Marceau

  86. A possible common pharmacophore in the non-peptide antagonists of the bradykinin B1 receptor

    Article • Trends in Pharmacological Sciences, March 2005, Elsevier

    Professor François Marceau

  87. International Union of Pharmacology. XLV. Classification of the Kinin Receptor Family: from Molecular Mechanisms to Pathophysiological Consequences

    Article • Pharmacological Reviews, February 2005, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Professor François Marceau

  88. Studies on rabbit natural and recombinant tissue factors: intracellular retention and regulation of surface expression in cultured cells

    Article • AJP Heart and Circulatory Physiology, January 2005, American Physiological Society

    Professor François Marceau

  89. The Kallikrein-Kinin System: Current and Future Pharmacological Targets

    Article • Journal of Pharmacological Sciences, January 2005, Japanese Pharmacological Society

    Professor François Marceau

  90. Bradykinin receptor ligands: therapeutic perspectives

    Article • Nature Reviews Drug Discovery, October 2004, Springer Science + Business Media

    Professor François Marceau

  91. A Novel Nonpeptide Antagonist of the Kinin B1 Receptor: Effects at the Rabbit Receptor

    Article • Journal of Pharmacology and Experimental Therapeutics, July 2004, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Professor François Marceau

  92. Massive Cell Vacuolization Induced by Organic Amines Such as Procainamide

    Article • Journal of Pharmacology and Experimental Therapeutics, March 2004, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Professor François Marceau

  93. Loss of function of vascular smooth muscle cells by nitric oxide-dependent and -independent interactions with tumorigenic cells

    Article • International Journal of Cancer, January 2004, Wiley

    Professor François Marceau

  94. A non-peptide antagonist unusually selective for the human form of the bradykinin B2 receptor

    Article • International Immunopharmacology, October 2003, Elsevier

    Professor François Marceau

  95. Wortmannin alters the intracellular trafficking of the bradykinin B2 receptor: role of phosphoinositide 3-kinase and Rab5

    Article • Biochemical Journal, October 2003, Portland Press Ltd.

    Professor François Marceau

  96. Characterization of a fluorescent conjugate of the rabbit angiotensin AT1 receptor

    Article • British Journal of Pharmacology, April 2003, Wiley

    Professor François Marceau

  97. Do angiotensin-converting enzyme inhibitors directly stimulate the kinin B1receptor?

    Article • AJP Heart and Circulatory Physiology, March 2003, American Physiological Society

    Professor François Marceau

  98. Tissue Kallikrein Actions at the Rabbit Natural or Recombinant Kinin B2 Receptors

    Article • Hypertension, February 2003, Wolters Kluwer Health

    Professor François Marceau

  99. High agonist-independent clearance of rabbit kinin B1receptors in cultured cells

    Article • AJP Heart and Circulatory Physiology, January 2003, American Physiological Society

    Professor François Marceau

  100. Kinin receptors: functional aspects

    Article • International Immunopharmacology, December 2002, Elsevier

    Professor François Marceau

  101. Contractile Effect of Anaphylatoxin C5a and of a Mimetic Peptide on the Human Umbilical Artery: Further Evidence for Leukocyte-Dependent Vasomotion

    Article • Journal of Cardiovascular Pharmacology, December 2002, Wolters Kluwer Health

    Professor François Marceau

  102. Bradykinin B 2 receptor gene polymorphism is associated with altered urinary albumin/creatinine values in diabetic patients

    Article • Canadian Journal of Physiology and Pharmacology, April 2002, Canadian Science Publishing

    Professor François Marceau

  103. Expression of kinin B1receptor in fresh or cultured rabbit aortic smooth muscle: role of NF-κB

    Article • AJP Heart and Circulatory Physiology, March 2002, American Physiological Society

    Professor François Marceau

  104. Agonist-Induced Translocation of the Kinin B1Receptor to Caveolae-Related Rafts

    Article • Molecular Pharmacology, March 2002, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Professor François Marceau

  105. Effects of two novel non-peptide antagonists at the rabbit bradykinin B2 receptor

    Article • Peptides, September 2001, Elsevier

    Professor François Marceau

  106. Absence of ligand-induced regulation of kinin receptor expression in the rabbit

    Article • British Journal of Pharmacology, August 2001, Wiley

    Professor François Marceau

  107. Ligand-Mediated Regulation of Kinin Receptors in the Rabbit

    Article • Biological Chemistry, January 2001, De Gruyter

    Professor François Marceau

  108. The contribution of angiotensin-converting enzyme (ACE) to the metabolism of kinins (bradykinin and des-Arg9-bradykinin) and effect of ACE inhibitors on their in vitro and in vivo metabolism

    Article • January 2001, Springer Science + Business Media

    Professor François Marceau

  109. The kallikrein-kininogen-kinin system: lessons from the quantification of endogenous kinins

    Article • Peptides, December 2000, Elsevier

    Professor François Marceau

  110. Altered frequency of a promoter polymorphism of the kinin B2 receptor gene in hypertensive African-Americans

    Article • American Journal of Hypertension, December 2000, Oxford University Press (OUP)

    Professor François Marceau

  111. Non-competitive pharmacological antagonism at the rabbit B1 receptor

    Article • British Journal of Pharmacology, November 2000, Wiley

    Professor François Marceau

  112. In vivo protein-DNA interactions at the kinin B1 receptor gene promoter: No modification on interleukin-1 beta or lipopolysaccharide induction

    Article • Journal of Cellular Biochemistry, August 2000, Wiley

    Professor François Marceau

  113. Antagonist-Induced Intracellular Sequestration of Rabbit Bradykinin B2 Receptor

    Article • Hypertension, June 2000, Wolters Kluwer Health

    Professor François Marceau

  114. Inflammatory hyperalgesia induced by zymosan in the plantar tissue of the rat: effect of kinin receptor antagonists

    Article • Immunopharmacology, February 2000, Elsevier

    Professor François Marceau

  115. Cloning and preliminary pharmacological characterization of the anaphylatoxin C5a receptor in the rabbit

    Article • British Journal of Pharmacology, September 1999, Wiley

    Professor François Marceau

  116. Characterization of a polymorphism in the coding region of the human C5a anaphylatoxin receptor

    Article • Immunogenetics, June 1999, Springer Science + Business Media

    Professor François Marceau

  117. Kinin receptors

    Article • Clinical Reviews in Allergy & Immunology, December 1998, Springer Science + Business Media

    Professor François Marceau

  118. Interleukin 8 (IL-8) Induces the Expression of Kinin B1Receptor in Human Lung Fibroblasts

    Article • Biochemical and Biophysical Research Communications, December 1998, Elsevier

    Professor François Marceau

  119. Altered frequency of a promoter polymorphic allele of the kinin B receptor gene in inflammatory bowel disease

    Article • Gastroenterology, November 1998, Elsevier

    Professor François Marceau

  120. Down-regulation of interleukin-1β production and PGE2 accumulation by an indomethacin-phenylalanine derivative in human monocytes

    Article • Life Sciences, May 1998, Elsevier

    Professor François Marceau

  121. Human kallikrein hK2 has low kininogenase activity while prostate-specific antigen (hK3) has none

    Article • Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, November 1997, Elsevier

    Professor François Marceau

  122. The kinin B 1 receptor: an inducible G protein coupled receptor

    Article • Canadian Journal of Physiology and Pharmacology, June 1997, Canadian Science Publishing

    Professor François Marceau

  123. Oxidative Stress Induced Actin Reorganization Mediated by the p38 Mitogen-Activated Protein Kinase/Heat Shock Protein 27 Pathway in Vascular Endothelial Cells

    Article • Circulation Research, March 1997, Wolters Kluwer Health

    Professor François Marceau

  124. Kinin B1 Receptor Induction and Inflammination

    Article • January 1997, Elsevier

    Professor François Marceau

  125. The kinin B1 receptor: an inducible G protein coupled receptor

    Article • Canadian Journal of Physiology and Pharmacology, January 1997, Canadian Science Publishing

    Professor François Marceau

  126. Evidence for vascular tone regulation by resident or infiltrating leukocytes

    Article • Biochemical Pharmacology, November 1996, Elsevier

    Professor François Marceau

  127. Mechanism of the contractile effect of diaspirin-cross-linked hemoglobin in rat isolated aorta strip denuded of endothelium as revealed using an oil-immersion procedure

    Article • Canadian Journal of Physiology and Pharmacology, October 1996, Canadian Science Publishing

    Professor François Marceau

  128. Structure and Genomic Organization of the Human B1Receptor Gene for Kinins (BDKRB1)

    Article • Genomics, May 1996, Elsevier

    Professor François Marceau

  129. Mechanism of the contractile effect of diaspirin-cross-linked hemoglobin in rat isolated aorta strip denuded of endothelium as revealed using an oil-immersion procedure

    Article • Canadian Journal of Physiology and Pharmacology, January 1996, Canadian Science Publishing

    Professor François Marceau

  130. Regulation of kinin-induced contraction and DNA synthesis by inflammatory cytokines in the smooth muscle of the rabbit aorta

    Article • British Journal of Pharmacology, September 1995, Wiley

    Professor François Marceau

  131. Mode of action of thrombin in the rabbit aorta

    Article • British Journal of Pharmacology, July 1995, Wiley

    Professor François Marceau

  132. Kinin B1 receptors: a review

    Article • Immunopharmacology, June 1995, Elsevier

    Professor François Marceau

  133. Recombinant Human Hemoglobin (rHb1.1) Selectively Inhibits Vasorelaxation Elicited by Nitric Oxide Donors in Rabbit Isolated Aortic Rings

    Article • Journal of Cardiovascular Pharmacology, April 1995, Wolters Kluwer Health

    Professor François Marceau

  134. Development of a binding assay for the B1 receptors for kinins

    Article • Immunopharmacology, March 1995, Elsevier

    Professor François Marceau

  135. Quantification of des-Arg9-bradykinin using a chemiluminescence enzyme immunoassay: application to its kinetic profile during plasma activation

    Article • Journal of Immunological Methods, January 1995, Elsevier

    Professor François Marceau

  136. Inflammatory Peptides at the Beginning of Hemodialysis in Asymptomatic Patients Treated or Not with Angiotensin l-Converting Inhibitors

    Article • January 1995, Karger Publishers

    Professor François Marceau

  137. Further analysis of the upregulation of bradykinin B1 receptors in isolated rabbit aorta by using metabolic inhibitors

    Article • European Journal of Pharmacology, December 1994, Elsevier

    Professor François Marceau

  138. Recombinant Human Hemoglobin Inhibits Both Constitutive and Cytokine-Induced Nitric Oxide-Mediated Relaxation of Rabbit Isolated Aortic Rings

    Article • Journal of Cardiovascular Pharmacology, August 1994, Wolters Kluwer Health

    Professor François Marceau

  139. Recombinant Human Hemoglobin Inhibits Both Constitutive and Cytokine-Induced Nitric Oxide-Mediated Relaxation of Rabbit Isolated Aortic Rings

    Article • Journal of Cardiovascular Pharmacology, August 1994, Wolters Kluwer Health

    Professor François Marceau

  140. Epidermal growth factor-induced rapid relaxation of the isolated rabbit mesenteric artery

    Article • European Journal of Pharmacology, June 1994, Elsevier

    Professor François Marceau

  141. The nonpeptide WIN 64338 is a bradykinin B2 receptor antagonist.

    Article • Proceedings of the National Academy of Sciences, May 1994, Proceedings of the National Academy of Sciences

    Professor François Marceau

  142. Aminopeptidase modulation of the pharmacological responses to synthetic thrombin receptor agonists

    Article • European Journal of Pharmacology, March 1994, Elsevier

    Professor François Marceau

  143. Vascular mode of action of kinin B1 receptors and development of a cellular model for the investigation of these receptors

    Article • British Journal of Pharmacology, August 1993, Wiley

    Professor François Marceau

  144. Synthetic C5a receptor agonists

    Article • Biochemical Pharmacology, March 1993, Elsevier

    Professor François Marceau

  145. Synthesis and pharmacological evaluation of amide derivatives of non-steroidal anti-inflammatory drugs

    Article • Inflammopharmacology, September 1992, Springer Science + Business Media

    Professor François Marceau

  146. Dissociation of the antimicrobial activity of bacitracin USP from its renovascular effects.

    Article • Antimicrobial Agents and Chemotherapy, May 1992, ASM Journals

    Professor François Marceau

  147. Effects of experimental conditions on the production of interleukin-1α and -1β by human endothelial cells cultured in vitro

    Article • International Journal of Immunopharmacology, May 1992, Elsevier

    Professor François Marceau

  148. Synergism between the contractile effect of epidermal growth factor and that of des-Arg9-bradykinin or of α.-thrombin in rabbit aortic rings

    Article • British Journal of Pharmacology, April 1992, Wiley

    Professor François Marceau

  149. Comparison of two classes of non-peptide drugs as antagonists of neutrophil receptors for f-Met-Leu-Phe

    Article • Biochemical Pharmacology, February 1992, Elsevier

    Professor François Marceau

  150. Human interleukin-1 induces a rapid relaxation of the rabbit isolated mesenteric artery

    Article • British Journal of Pharmacology, June 1991, Wiley

    Professor François Marceau

  151. Pulse exposure to protein synthesis inhibitors enhances vascular responses to des-Arg9-bradykinin: possible role of interleukin-1

    Article • British Journal of Pharmacology, May 1991, Wiley

    Professor François Marceau

  152. The interaction of 3,5-pyrazolidinedione drugs with receptors for f-Met-Leu-Phe on human neutrophil leukocytes: a study of the structure–activity relationship

    Article • Canadian Journal of Physiology and Pharmacology, March 1991, Canadian Science Publishing

    Professor François Marceau

  153. Long-term culture and characterization of human limbal microvascular endothelial cells

    Article • Experimental Eye Research, December 1990, Elsevier

    Professor François Marceau

  154. Contractile effect of the chemotactic factors f-Met-Leu-Phe and C5a on the human isolated umbilical artery. Role of cyclooxygenase products and tissue macrophages

    Article • Circulation Research, November 1990, Wolters Kluwer Health

    Professor François Marceau

  155. Pharmacological modulation of interleukin 1 production by cultured endothelial cells from human umbilical veins

    Article • Immunopharmacology, March 1990, Elsevier

    Professor François Marceau

  156. Bacitracin U.S.P. contains a factor that stimulates receptors for 5-hydroxytryptamine on rabbit aortic strips

    Article • Life Sciences, January 1990, Elsevier

    Professor François Marceau

  157. Pharmacological modulation of the up-regulated responses to des-Arg9-bradykinin in vivo and in vitro

    Article • Immunopharmacology, May 1989, Elsevier

    Professor François Marceau

  158. Prostacyclin release induced by neurokinins in cultured human endothelial cells

    Article • Canadian Journal of Physiology and Pharmacology, February 1989, Canadian Science Publishing

    Professor François Marceau

  159. Small fibronectin fragments induce endothelium-dependent vascular relaxations

    Article • Canadian Journal of Physiology and Pharmacology, June 1988, Canadian Science Publishing

    Professor François Marceau

  160. Effect of glucocorticoids, monokines and growth factors on the spontaneously developing responses of the rabbit isolated aorta to des-Arg9-bradykinin

    Article • British Journal of Pharmacology, April 1988, Wiley

    Professor François Marceau

  161. Studies on the effects of disease-modifying antirheumatic drugs on lipoxygenase product synthesis in human neutrophils in vitro

    Article • International Journal of Immunopharmacology, January 1988, Elsevier

    Professor François Marceau

  162. Effects of the anaphylatoxins on circulation

    Article • Immunopharmacology, October 1987, Elsevier

    Professor François Marceau

  163. The ability of des-Arg9-bradykinin to relax rabbit isolated mesenteric arteries is acquired during in vitro incubation

    Article • European Journal of Pharmacology, October 1987, Elsevier

    Professor François Marceau

  164. Studies on the induction of pharmacological responses to des-Arg9-bradykinin in vitro and in vivo

    Article • British Journal of Pharmacology, October 1987, Wiley

    Professor François Marceau

  165. Effects of low molecular weight fibrin degradation products 6A and 6D on rabbit aorta strips

    Article • October 1987, Springer Science + Business Media

    Professor François Marceau

  166. Carboxypeptidase N (Kininase I) activity in blood and synovial fluid from patients with arthritis

    Article • Life Sciences, September 1987, Elsevier

    Professor François Marceau

  167. Mitogenic effect of bradykinin and of des-Arg9-bradykinin on cultured fibroblasts

    Article • Life Sciences, December 1986, Elsevier

    Professor François Marceau

  168. Anaphylatoxin C5a fails to promote prostacyclin release in cultured endothelial cells from human umbilical veins

    Article • Immunopharmacology, October 1986, Elsevier

    Professor François Marceau

  169. Effects of the C5a anaphylatoxin and its relationship to cyclo-oxygenase metabolites in rabbit vascular strips

    Article • British Journal of Pharmacology, March 1985, Wiley

    Professor François Marceau

  170. Selective Induction of Cardiovascular Responses to des-Arg9-Bradykinin by Bacterial Endotoxin

    Article • Pharmacology, January 1984, Karger Publishers

    Professor François Marceau

  171. Rapid assay of human plasma carboxypeptidase N by high-performance liquid chromatographic separation of hippuryl-lysine and its product

    Article • Journal of Chromatography A, August 1983, Elsevier

    Professor François Marceau

  172. Pharmacology of kinins: Their relevance to tissue injury and inflammation

    Article • General Pharmacology The Vascular System, January 1983, Elsevier

    Professor François Marceau

  173. Kininases and vascular responses to kinins

    Article • European Journal of Pharmacology, February 1982, Elsevier

    Professor François Marceau

  174. Pharmacological characterization of the vascular permeability enhancing effects of kinins in the rabbit skin

    Article • Canadian Journal of Physiology and Pharmacology, September 1981, Canadian Science Publishing

    Professor François Marceau

  175. Induction of B1-receptors for kinins in the rabbit by a bacterial lipopolysaccharide

    Article • European Journal of Pharmacology, April 1981, Elsevier

    Professor François Marceau

  176. The degradation of bradykinin (BK) and of des-Arg 9 -BK in plasma

    Article • Canadian Journal of Physiology and Pharmacology, February 1981, Canadian Science Publishing

    Professor François Marceau

  177. Kinin receptors in experimental inflammation

    Article • Canadian Journal of Physiology and Pharmacology, May 1980, Canadian Science Publishing

    Professor François Marceau

  178. Cardiovascular actions of kinins in the rabbit

    Article • Canadian Journal of Physiology and Pharmacology, January 1979, Canadian Science Publishing

    Professor François Marceau

  179. De novo formation of vascular receptors for bradykinin

    Article • Canadian Journal of Physiology and Pharmacology, August 1978, Canadian Science Publishing

    Professor François Marceau

  180. The rabbit mesenteric vein: a specific bioassay for substance P

    Article • Canadian Journal of Physiology and Pharmacology, August 1978, Canadian Science Publishing

    Professor François Marceau